A growing body of evidence suggests that SphK(s) and S1P receptors may play an important role in the pathogenesis of AD and other neurodegenerative disorders, such as multiple sclerosis (MS), HIV and dementia. This evidence concerns the gene SPHK1 and Alzheimer disease.